This cell line represents a highly aggressive, invasive, and poorly differentiated triple-negative breast cancer cell line, as it lacks estrogen receptor (ER) and progesterone receptor (PR) expression, as well as HER2 (human epidermal growth factor receptor 2) amplification. This evidence concerns the gene ESR1 and triple-negative breast carcinoma.